Active Ingredient: NALBUPHINE HYDROCHLORIDE
Proprietary Name: NALBUPHINE HYDROCHLORIDE
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 10MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207595
Product Number: 001
Approval Date: Jan 11, 2019
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
